Jennifer Kahn’s ‘love GMOs’ article in NYT is propaganda, not journalism
By Stacy Malkan,
U.S. Right to Know
| 07. 21. 2021
Next week in Rome, world leaders will gather to discuss how to fix the food system amid one of the worst hunger crises in recent times. According to a new United Nations report on hunger, more than 2.37 billion people did not have adequate access to food in 2020. The Covid-19 pandemic has exposed weaknesses in food systems that were already failing to meet the needs of so many people.
Rather than addressing systemic solutions for hunger and poverty, however, leaders of the upcoming UN Food Systems Summit are ignoring human rights and pushing to expand genetic engineering and commodity crop monocultures that are deepening the crises and also not feeding the world, according to hundreds of groups that are boycotting next week’s events and organizing a counter summit.
All this context is missing from a 7,000 plus word promotional article for genetically engineered foods published this week in the New York Times Magazine. Jennifer Kahn reports that, “overblown fears have turned the public against genetically modified food” even though the “potential benefits have never been greater.”...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...